Oracle Corp Securities Lawsuit Investigation

Shamis & Gentile P.A., a law firm that advocates for investors who are victims of securities fraud, is investigating potential claims against Oracle Corp (ORCL).

If you purchased or held Oracle securities and suffered losses, you may be eligible to join this securities investigation and seek compensation.

About Oracle

Oracle provides enterprise software, integrated cloud services, and database technologies to 97% of Fortune 500 companies. Its core business lines include Oracle Cloud Infrastructure (OCI), Fusion and NetSuite SaaS applications, and industry-specific solutions such as Oracle Health.

Recent leadership changes were announced on September 22, 2025, with Clay Magouyrk and Mike Sicilia appointed as Co-CEOs and Safra Catz transitioning to Executive Vice Chair.

What’s Being Investigated

Shamis & Gentile P.A. is reviewing allegations that Oracle may not have fully disclosed all accounting issues related to its cloud computing business and its AI-driven growth outlook.

The investigation focuses on whether Oracle’s reported remaining performance obligations (RPO) and the timing of revenue from major contracts, such as a purported $300 billion deal with OpenAI, were accurately presented to investors.

New questions have emerged in August and September 2025. These include questions about the substance and timing of Oracle’s reported $455 billion backlog and the OpenAI contract, as well as concerns about internal controls, C-suite turnover, and workforce reductions.

As a result, past allegations about cloud accounting practices and Oracle’s public statements about its AI-driven growth trajectory have resurfaced.

Key Timeline

• August 19, 2025: Reports surface of Oracle cloud-unit layoffs and the departure of Chief Security Officer Mary Ann Davidson after 37 years. Investors allege these events contradicted prior assurances that AI expansion would not impact security or staffing.
• September 9, 2025: Oracle announces Q1 FY2026 results, highlighting a $455 billion RPO and a multi-year, multi-billion-dollar contract pipeline, including a reported $300 billion OpenAI deal.
• September 11, 2025: Short-seller, Jim Chanos publicly questions the quality and timing of Oracle’s backlog and OpenAI contract, reviving older cloud accounting allegations. Oracle shares fall 6% amid media coverage raising doubts about the backlog’s substance and the company’s reliance on a single customer.
• September 22, 2025: Oracle announces leadership changes, with two new Co-CEOs and Safra Catz moving to Executive Vice Chair.

Your Rights and Next Steps

This is an active investigation into potential breaches of fiduciary duty and possible securities law violations at Oracle Corp. If you owned Oracle stock during the relevant period and suffered losses, you may have the right to participate in a derivative action on behalf of the company.

Shareholders in a derivative action seek to hold directors and officers accountable for alleged oversight failures, misleading statements, or conflicts of interest. If the investigation develops into a lawsuit, you may be able to pursue claims for monetary recovery to the company, governance reforms, or both.

To preserve your rights, it is important to act promptly. Derivative actions often require that you held shares during the relevant period and continue to hold them through the resolution of the case.

The process may involve a books-and-records demand under Delaware law to obtain board materials and internal communications.

You May Be Entitled to Compensation

Securities investigations are time-sensitive. If you purchased or held Oracle securities and experienced losses, you may be eligible to join this investigation and seek compensation or governance reforms on behalf of Oracle.

To participate, complete the form below to join the investigation. Your timely action may help protect your rights and support efforts to improve Oracle’s governance.